Search
for

    Sort by

    Research 751–780 of 863

    1. Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy MOJ bioequivalence & bioavailability · 2017 · 1 citations
    2. Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients Journal of endocrinology and diabetes · 2015 · 1 citations
    3. Medical Therapy for Female Pattern Hair Loss (FPHL) Hair transplant forum international · 2014 · 1 citations
    4. A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency Hair transplant forum international · 2013 · 1 citations
    5. Lipid nanocarriers as innovative strategies for hair regrowth Discover Nano · 2026
    6. Combination Therapy in Androgenetic Alopecia: A Network Meta-Analysis of Minoxidil and Other Pharmacological Agents Aesthetic Plastic Surgery · 2026
    7. Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches Premier journal of science. · 2026
    8. GPRC6A-Duox1 Axis Regulates the Hair Cycle Through H2O2 Generation Tissue Engineering and Regenerative Medicine · 2026
    9. Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization Biomolecules · 2026
    10. Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives Dermato · 2026
    11. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments American Journal of Clinical Dermatology · 2026
    12. The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives Biology · 2026
    13. Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia Dermatologica Sinica · 2026
    14. Hormonal Therapies for Alopecia Updates in clinical dermatology · 2026
    15. Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity Current Issues in Molecular Biology · 2025
    16. Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives Cosmetics · 2025
    17. The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results Journal of Cosmetic Dermatology · 2025
    18. Raw data collected during the study. Faculty of 1000 Research Ltd · 2025
    19. Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review Clinical Endocrinology · 2025
    20. Polycystic ovary syndrome: pragmatic management across levels of care Gynecological Endocrinology · 2025
    21. Cinchonine‐loaded nanostructured lipid carriers for targeted delivery to hair follicles Journal of Pharmacy & Pharmacognosy Research · 2025
    22. Exosome-based Therapies for Androgenetic Alopecia: Mechanisms, MicroRNAs, and Clinical Prospects Gene Expression · 2025
    23. Unlocking the Potential of Rosemary in Alopecia: A Narrative Review of Evidence on Mechanism, Applications and Challenges Journal of Advanced Trends in Medical Research · 2025
    24. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    25. Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials Frontiers in Medicine · 2025
    26. Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation Aesthetic Plastic Surgery · 2025
    27. A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia Cureus · 2025
    28. Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment Drug Design Development and Therapy · 2025
    29. Impact of conventional and advanced therapies in functional hair follicular regeneration in pesticide-induced hair loss: a Pharmacological perspective of review Journal of Drug Delivery and Therapeutics · 2025
    30. Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review American Journal of Clinical Dermatology · 2025